API-广州沙龙体育汉方现代药业有限公司

Category	Product Name	Standard	CAS No.	Remarks
Medicinal oils series	Soybean Oil	CP/USP	8001-22-7	CDE registration No.F20209990540，status “A”
Medicinal oils series	Purified Olive Oil（For Injection）	USP/EP	8001-25-0	CDE registration No.Y20190000997，status “A”
Medicinal oils series	Structured Triglyceride	Enterprise Standard	--	R&D
Medicinal oils series	Purified Fish Oil	USP/EP	8016-13-5	R&D
Medicinal oils series	Sodium Oleate（For injection）	Enterprise Standard	16558-02-4	CDE registration No.F20220000120
Medicinal oils series	Soybean Oil for Injection	CP/USP/EP	8001-22-7	CDE registration No.Y20190000635，status “A”
Medicinal oils series	Medium Chain Triglycerides	CP/USP/EP	65381-09-1	CDE registration No.Y20200001227，status “A”
Medicinal Phospholipids series	Purified Egg lecithin / Egg Phospholipids	CP/USP/EP	93685-90-6	CDE registration No.F20190001049，status “A”，DMF#35483
Medicinal Phospholipids series	Egg Phosphatidyl Choline	CP	93685-90-6	CDE registration No.F20170000086，status “A”
Medicinal Phospholipids series	Polyene Phosphatidyl Choline	Enterprise Standard	8002-43-5	R&D
Medicinal Phospholipids series	Cholesterol（For injection）	CP	57-88-5	CDE registration No.F20170000625，status “A”
Medicinal Phospholipids series	DSPE	Enterprise Standard	1069-79-0	R&D
Medicinal Phospholipids series	DOPE	Enterprise Standard	4004-05-1	R&D
Medicinal Phospholipids series	EPG	Enterprise Standard	383907-64-0	R&D
Medicinal Phospholipids series	DSPC	Enterprise Standard	816-94-4	R&D
Medicinal Phospholipids series	DOPC	Enterprise Standard	4235-95-4	R&D
Medicinal Phospholipids series	Sphingomyelin/SM	Enterprise Standard	383907-87-7	R&D
Medicinal Phospholipids series	DSPG-Na	Enterprise Standard	200880-42-8	R&D
Medicinal Phospholipids series	DPPG-Na	Enterprise Standard	67232-81-9	R&D
Oncology APIs	Vincristine Sulfate	CP/USP/EP/IP	2068-78-2	CDE registration No.Y20190009906，status “A”，DMF#18579
Oncology APIs	Vinblastine Sulfate	CP/USP/EP/IP	143-67-9	CDE registration No.Y20190007637，status “A”
Oncology APIs	Vinorelbine Tartrate	CP/USP/EP/IP	125317-39-7	CDE registration No.Y20190006188，status “A”，DMF#25783
Oncology APIs	Vindesine Sulfate	CP/EP	59917-39-4	CDE registration No.Y20190007636，status “A”
Cardiovascular APIs	Methyl Hesperidin	National Drug Standard	11013-97-1	CDE registration No.Y20190007574，status “A”
Cardiovascular APIs	Tolperisone Hcl	National Drug Standard	3644-61-9	CDE registration No.Y20190008322，status “A”
Cardiovascular APIs	Metoprolol Tartrate	CP	56392-17-7	CDE registration No.Y20190007575，status “A”
Cardiovascular APIs	Trimetazidine Hcl	CP	13171-25-0	CDE registration No.Y20190007374，status “A”
Anticholinergic APIs	Scopolamine Hydrobromide	CP	114-49-8	CDE registration No.Y20190001970，status “A”
Anticholinergic APIs	Scopolamine Butylbromide	CP/EP	149-64-4	CDE registration No.Y20190007630，status “A”
Others	Propyl Gallate	CP/USP/EP	121-79-9	CDE registration No.Y20190007577，status “A”
Others	Bifonazole	CP	60628-96-8	CDE registration No.Y20190007629，status “A”
Others	Clotrimazole	CP	23593-75-1	CDE registration No.Y20190007626，status “A”
Functional additive	Eggyolk oil	Enterprise Standard	8001-17-0	--
Functional additive	Egg Protein Powder	Enterprise Standard	--	--